|Table of Contents|

A comparative analysis of VATS with thoracotomy for patients with stage Ⅰ NSCLC

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2017 03
Page:
371-374
Research Field:
Publishing date:

Info

Title:
A comparative analysis of VATS with thoracotomy for patients with stage Ⅰ NSCLC
Author(s):
Hou Wei; Li Jia; Gao Xiaojian
Thoracic Surgery Department，Zaoyang First People's Hospital,Hubei Zaoyang 441200，China.
Keywords:
VATS; thoracotomy; NSCLC; postoperative life quality
PACS:
R730.5；R734.2
DOI:
10.3969/j.issn.1672-4992.2017.03.009
Abstract:
Objective：To compare the early clinical effects of patients with stage I NSCLC treated by VATS and thoracotomy.Methods：Totally 75 cases of NSCLC in stage I were randomly divided into two groups：VATS group (n=36) and thoracotomy group (n=39).The operative index，laboratory parameters and quality of life were observed.Results：Blood loss，chest tube drainage，postoperative ambulation first time，postoperative hospital stay in the VATS group were (102±28.9)ml，(254±56.3)ml，(2±0.8)d，（10±2.3)d significantly lower than those (174±25.7)ml，(405±46.8)ml，(4±0.9)d，(13±1.7)d of thoracotomy group (P<0.05).There was no difference of lymph node dissection and postoperative recurrence between the two groups （P>0.05).The blood amount of high-sensitivity C-reactive protein was (9.32±1.75)mg/L on the 3rd postoperative day in the VATS significantly lower than that of thoracotomy group (10.57±2.25)mg/L,P<0.05.After surgery 1，3，6 months，the FEV1 of patients was (1.67±0.14)L/min in VATS group significantly higher than thoracotomy group (1.59±0.18)L/min (P<0.05).The score of postoperative quality of life was 117.6±6.43 in VATS group significantly higher than 113.2±4.83 in the thoracoscopic group (P<0.05).Conclusion：VATS is superio to thoraocotomy for stage I NSCLC with minimum injury and better post operative quality of life.

References:

［1］Guerra M，Neves P，Miranda J.Surgical treatment of non-small-cell lung cancer in octogenarians［J］.Interactive Cardiovascular and Thoracic Surg，2013，16(5)：673-680.
［2］Lackey A，Donington JS.Surgical management of lung cancer.seminars in interventional radiology［J］.Cancer，2013，30(2)：133-140.
［3］Komatsu H，Mizuguchi S，Izumi N，et al.Sialyl Lewis X as a predictor of skip N2 metastasis in clinical stage Ia non-small cell lung cancer［J］.World J Surg Oncol，2013，11：309.
［4］Varela G，Thomas PA.Surgical management of advanced non-small cell lung cancer［J］.J Thoracic Dis，2014，6(Suppl 2)：S217-S223.
［5］Gould MK，Donington J，Lynch WR，et al.Evaluation of individuals with pulmonary nodules：when is it lung cancer：diagnosis and management of lung cancer，3rd ed：american college of chest physicians evidence-based clinical practice guidelines［J］.Chest，2013，143(5 Suppl)：e93S-e120S.
［6］Cao C，Manganas C，Ang SC，et al.Video-assisted thoracic surgery versus open thoracotomy for non-small cell lung cancer：a meta-analysis of propensity score-matched patients［J］.Interactive Cardiovascular and Thoracic Surg，2013，16(3)：244-249.
［7］Berry MF，Onaitis MW，Tong BC，et al.Feasibility of hybrid thoracoscopic lobectomy and en-bloc chest wall resection［J］.Eur J Cardio-Thoracic Surg，2012，41(4)：888-892.
［8］Higuchi M，Yaginuma H，Yonechi A，et al.Long-term outcomes after video-assisted thoracic surgery (VATS) lobectomy versus lobectomy via open thoracotomy for clinical stage Ia non-small cell lung cancer［J］.J Cardiothoracic Surg，2014，9：88.
［9］Crabtree T，Puri V，Robinson C，et al.Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy［J］.J Thoracic Cardiovascular Surg，2014，147(4)：1183-1192.
［10］Liu J，Zhang X，Lei GY.Effect of VATS in thoracotomy for resectable lung cancer［J］.Modern Oncology，2016，24(10)：1555-1557.［刘佳，张曦，雷光焰.胸腔镜与开胸手术治疗肺癌的对比研究［J］.现代肿瘤医学，2016，24(10)：1555-1557.］
［11］Vest MT，Herrin J，Soulos PR，et al.Use of new treatment modalities for non-small cell lung cancer care in the medicare population［J］.Chest，2013，143(2)：429-435.

Memo

Memo:
-
Last Update: 2016-12-29